Matches in Wikidata for { <http://www.wikidata.org/entity/Q96113780> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q96113780 description "article scientifique publié en 2020" @default.
- Q96113780 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96113780 description "scientific article published on 02 June 2020" @default.
- Q96113780 description "wetenschappelijk artikel" @default.
- Q96113780 description "наукова стаття, опублікована 2 червня 2020" @default.
- Q96113780 name "Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial" @default.
- Q96113780 name "Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial" @default.
- Q96113780 type Item @default.
- Q96113780 label "Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial" @default.
- Q96113780 label "Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial" @default.
- Q96113780 prefLabel "Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial" @default.
- Q96113780 prefLabel "Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial" @default.
- Q96113780 P1433 Q96113780-31F61C1A-5347-4281-ADA2-FCD84D65CE1A @default.
- Q96113780 P1476 Q96113780-05F93B3B-88D8-4DB3-A2F5-19584A7F7CEB @default.
- Q96113780 P2093 Q96113780-0076E0A2-20D8-493D-A40A-9D599CC2C3F0 @default.
- Q96113780 P2093 Q96113780-040CEA99-C26B-4751-8712-B24F70EF952A @default.
- Q96113780 P2093 Q96113780-3C96503B-F2A8-47DE-BA04-DBA9FCAC0D79 @default.
- Q96113780 P2093 Q96113780-587A0D1D-1645-49C2-ABB0-8D0A1CEBF81A @default.
- Q96113780 P2093 Q96113780-87383952-3DCE-42E9-A335-E00AC9F9271C @default.
- Q96113780 P2093 Q96113780-B525DC45-820E-4C1D-8D0E-440601D6A65C @default.
- Q96113780 P2093 Q96113780-EEEF07CE-8520-40CA-B677-14B6F2DFB93C @default.
- Q96113780 P275 Q96113780-9e88b31c-6794-42c3-a24d-1a6521a8c294 @default.
- Q96113780 P31 Q96113780-75829FEF-D9EE-4FAE-ADC7-155BF092EF14 @default.
- Q96113780 P356 Q96113780-032BABAD-A545-4350-AF1F-C72B6D46500B @default.
- Q96113780 P50 Q96113780-A31F4E34-CC07-4434-B0FF-EAB7376646FD @default.
- Q96113780 P577 Q96113780-4E757702-58A9-4B7E-86A2-7430D20741A3 @default.
- Q96113780 P6216 Q96113780-b533d692-c763-4a9b-bbc9-51b520d21898 @default.
- Q96113780 P698 Q96113780-C7A5446D-0374-4F7F-A524-BA9BD0F0BA7F @default.
- Q96113780 P921 Q96113780-0F59C89B-F650-413A-A57D-64F21D21E883 @default.
- Q96113780 P932 Q96113780-E0EC1C91-E211-42DB-910F-D09AF0A65534 @default.
- Q96113780 P356 DGAA321 @default.
- Q96113780 P698 32485734 @default.
- Q96113780 P1433 Q3186902 @default.
- Q96113780 P1476 "Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial" @default.
- Q96113780 P2093 "Anne Pernille Ofstad" @default.
- Q96113780 P2093 "Bernard Zinman" @default.
- Q96113780 P2093 "Christoph Wanner" @default.
- Q96113780 P2093 "David H Fitchett" @default.
- Q96113780 P2093 "Jyothis T George" @default.
- Q96113780 P2093 "Michaela Mattheus" @default.
- Q96113780 P2093 "Silvio E Inzucchi" @default.
- Q96113780 P275 Q20007257 @default.
- Q96113780 P31 Q13442814 @default.
- Q96113780 P356 "10.1210/CLINEM/DGAA321" @default.
- Q96113780 P50 Q37373977 @default.
- Q96113780 P577 "2020-06-02T00:00:00Z" @default.
- Q96113780 P6216 Q50423863 @default.
- Q96113780 P698 "32485734" @default.
- Q96113780 P921 Q5373824 @default.
- Q96113780 P932 "7382052" @default.